Galena Biopharma, Inc. (Nasdaq: GALE) announced the recommendation from the Independent Data Monitoring Committee (IDMC) on the interim analysis for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE